Ireland· IE-PA-EU/1/25/1963/002
Eiyzey 40 mg/mL solution for injection in a vial
A aflibercept product containing aflibercept, registered in Ireland by Zaklady Farmaceutyczne Polpharma S.A.. The same ATC class is registered in 11 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Aflibercept is registered in 11 of 19 countries.
Countries holding a registration under ATC S01LA05 (aflibercept), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Aflibercept · ATC S01LA05
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Aflibercept
- Manufacturer
- Zaklady Farmaceutyczne Polpharma S.A.
- Country
- Ireland (IE)
- ATC code
- S01LA05
- ATC class
- Aflibercept
- Defined daily dose
- 0.018 DE, IVT
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/25/1963/002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Aflibercept in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAFIVEGSTADA Arzneimittel AG, Bad Vilbel
- BelgiumAfiveg 40 mg/mlStada Arzneimittel
- SwedenAfiveg 40 mg/ml Injektionsvätska, lösningSTADA Arzneimittel AG
- IcelandAfivegSTADA Arzneimittel AG
- PolandAfivegSTADA Arzneimittel AG
- NetherlandsAfiveg 40 mg/ml oplossing voor injectieStada Arzneimittel AG
- SpainAFQLIR 40 MG/ML SOLUCION INYECTABLE EN JERINGA PRECARGADASandoz Gmbh
- SwitzerlandAflivis 40 mg/ml, InjektionslösungOmniVision AG
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Vgenfli
- Iceland · Afiveg, Afqlir
- Liechtenstein · Afiveg, Afqlir
- Norway · Afiveg, Afqlir
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/df27ccb0-9da4-4f74-aceb-8bfd000ccd26 GET /v1/drugs/df27ccb0-9da4-4f74-aceb-8bfd000ccd26?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection in vial",
"routes": [
"Intravitreal use"
],
"source": "hpra",
"atc_all": [
"S01LA05"
],
"strength": null,
"pa_number": "EU/1/25/1963/002",
"substances": [
"Aflibercept"
],
"legal_basis": "Similar biological application (Article 10(4) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "14/08/2025",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about aflibercept.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.